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constellation described here hints at the possible link be-
tween hepatitis B and  M. tuberculosis infection and the de-
velopment of Takayasu’s arteritis. The case also supports the 
little evidence available indicating that treatment of active 
hepatitis B infection could positively influence the course of 
Takayasu’s arteritis.  © 2017 S. Karger AG, Basel 
 Introduction 
 Takayasu’s arteritis (TA) is a rare disease of unknown 
etiology  [1] . It is characterized by an inflammatory arte-
ritis classically involving the large vessels of Asian women 
in childbearing age, which results in stenosis of the af-
fected arteries. The Chapel Hill Consensus Conference 
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 Abstract 
 We report a rare case of Takayasu’s arteritis with isolated pul-
monary artery stenosis in the presence of active hepatitis B 
and latent  Mycobacterium tuberculosis infection in a middle-
aged Asian woman who initially presented with severe dys-
pnea on exertion and recurrent syncope, occasional burning 
chest pains, and fatigue. Therapy of the active hepatitis B 
and latent  M. tuberculosis infection together with a course of 
methotrexate led to a slight reversal of the symptoms, as an-
gioplasty with or without stenting was not an option. The 
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 Established Facts 
 • The development of Takayasu’s arteritis and infection with hepatitis B virus and  Mycobacterium tu-
berculosis might be linked. 
 Novel Insights 
 • Isolated pulmonary artery involvement and its correlated symptoms can be the first and single signs 
of Takayasu’s arteritis. 
 • Treatment of concomitant active hepatitis B might positively influence Takayasu’s arteritis symptoms. 
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on the Nomenclature of Systemic Vasculitis defines it as 
“granulomatous inflammation of the aorta and its major 
branches”  [2] . The subclavian artery is most commonly 
affected by TA. Involvement of the pulmonary arteries 
has been described in 10–50% of cases of TA, yet only 
about 15 cases of isolated involvement of the pulmonary 
arteries have been reported  [3, 4] , none of which appeared 
to be related to hepatitis. We report a case of isolated pul-
monary artery involvement by TA in a middle-aged Asian 
woman concomitantly suffering from newly diagnosed 
active hepatitis B virus (HBV) and latent  Mycobacterium 
tuberculosis infection.
 Case Report 
 A 56-year-old woman of Asian descent was admitted because 
of severe dyspnea on exertion that had slowly progressed over the 
past 12 months. She had also experienced recurrent syncope on 
exertion and complained of occasional burning chest pain and 
vague fatigue. Her medical history was otherwise unremarkable 
except for a chronic lower back pain and mild polyneuropathy in 
both feet verified by clinical neurological examination.
 On clinical examination, the patient was afebrile (36.6   °    C), 
blood pressure and heart rate were normal (110/85 mm Hg and 96/
min, respectively) with no blood pressure difference between the 
arms. Auscultation of the lung was normal, while cardiac ausculta-
tion revealed a harsh 3/6 systolic ejection murmur with radiation 
to the back. A diagnostic workup was initiated.
 Echocardiography showed normal right ventricular systolic 
function with no evidence of pulmonary arterial hypertension. 
Pulmonary function testing revealed normal dynamic and static 
lung volumes and normal diffusion capacity for carbon monoxide 
after correction for ethnicity. However, on a bicycle stress test the 
patient managed a workload of 85% predicted when oxygen satu-
ration decreased to 85% on ambient air. On chest computed to-
mography, the wall of the right pulmonary artery was thickened 
and surrounded by infiltrative mediastinal masses; there were no 
signs of a currently active tuberculosis (TB) infection. However, 
there were multiple subpleural retractile fibrotic lung scars, pre-
dominantly in the right upper and lower lobe. Chest magnetic res-
onance imaging showed severe tubular stenosis (minimal diameter 
4 mm) of the entire right branch of the pulmonary artery extending 
from its offset at the bifurcation of the main pulmonary artery into 
its main branches, which were occluded except for the descending 
artery and the lateral lower lobe segmental artery. Positron emis-
sion tomography with  18 F-fluorodeoxyglucose showed mild up-
take by the vessel wall and the perivascular tissue of the right pul-
monary artery (standardized uptake value = 4.9) ( Fig. 1 a–c).
 Laboratory tests revealed a high erythrocyte sedimentation rate 
(ESR, 81 mm/h), a mildly elevated C-reactive protein (15–25 mg/L, 
normal range <5 mg/L), an elevated rheumatoid factor (50 U/mL, 
normal range <15 IU/mL), and elevated aspartate aminotransfer-
ase (74 U/L) and alanine aminotransferase (84 U/L). Serologic test-
ing revealed active chronic HBV infection (HBs antigen 8,038 U/L, 
HBs antibody negative, HBc antibodies positive, HBe antibody 
positive, HBV-DNA 65,000 U/mL); a Mantoux tuberculin skin test 
and an interferon-γ release assay were positive. The patient had 
never received bacillus Calmette-Guérin vaccinations; a related 
scar on the left arm is not present. Repeated blood cultures were 
sterile, and repetitive sputum samplings were negative for myco-
bacteria. Differential blood count, urine analysis, serum protein 
electrophoresis, human immunodeficiency virus,  Treponema pal-
lidum particle agglutination assay, hepatitis C virus, antineutro-
phil cytoplasmic antibodies, antinuclear antibodies, anticitrulli-
nated peptide antibodies, and anticentromere antibodies as well as 
complement for C3/C4, cryoprecipitation, and antibodies to  His-
toplasma capsulatum were normal.
 After endobronchial ultrasound-guided biopsy of the tissue 
surrounding the right pulmonary artery, there was no evidence of 
malignancy or infection with TB ( Fig. 2 ). The presumptive diag-
nosis of TA was made, and a therapy with oral prednisone 1 mg/
kg was initiated and combined with azathioprine 100 mg/day. Pri-
or to that, in order to avoid reactivation of hepatitis or TB, a ther-
apy was started with entecavir 0.5 mg once daily and isoniazid 300 
mg once daily. Due to the length of the stenosis and its associated 
branch occlusions, balloon angioplasty with or without stenting 
was not deemed beneficial in this case.
 The immunosuppressive therapy initially led to a reduction of 
dyspnea, less frequent chest pain, and markedly reduced fatigue. 
Within 3 months, C-reactive protein and ESR were decreasing to 
normal levels, and the magnetic resonance angiography of the pul-
monary arteries showed regression of the stenosis of the right pul-
monary artery ( Fig. 3 ). Prednisone was tapered and stopped dur-
ing this time.
 Within a few months, the disease relapsed under therapy with 
azathioprine, with newly aggravated chest pain, dyspnea, and an 
increase in ESR. At that point, chronic HBV infection was well 
controlled with less than 20 copies of viral DNA/mL, and trans-
aminases had regressed to normal. High-dose methylprednisolone 
treatment (2.5 g over 3 days) was initiated, and methotrexate was 
started with rapid dose escalation to 20 mg weekly, replacing aza-
thioprine. This step-up in therapy lead to a stable pulmonary situ-
ation up to the present (18 months), with low ESR (8 mm/h) and 
marked reduction of perivascular inflammation and fluorodeoxy-
glucose activity in imaging studies, while the degree of branch pul-
monary artery stenosis remained unchanged.
 Discussion 
 The case presented here is unusual for several reasons. 
Disease onset was rather late, as TA usually occurs in 
women between 10 and 40 years of age. Additionally, el-
evated rheumatoid factor is rare in TA and usually related 
to concomitant rheumatoid arthritis  [5, 6] . The patient 
presented has intermittent lower back pain but otherwise 
showed no signs of arthritis.
 What makes the presented case unique is the isolated 
involvement of the pulmonary artery and the concomi-
tant (latent) TB and HBV infections. It appears that
isolated pulmonary artery involvement and its corre-
lated symptoms can be the first and single signs of TA, 
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with only 15 cases reported so far  [3] , none of which 
were associated with concomitant TB and HBV infec-
tions.
 We believe that the patient has latent TB infection on 
the basis of a positive interferon-γ release assay, since tu-
berculin skin testing is not sufficient in patients with TA 
 [7] , even though the patient never had bacillus Calmette-
Guérin vaccination and no postvaccination scar is pres-
ent. Additionally, we found no evidence for active TB in 
biopsy samples or chest computed tomography. Howev-
er, the latter revealed multiple subpleural retractile fibrot-
ic lung scars, predominantly in the right upper and lower 
lobe, which are nonspecific, yet could be the result of a 
previous TB infection.
a
b
c
 Fig. 1.  a Contrast-enhanced computed tomography depicting a 
tubular stenosis of the right pulmonary artery (arrowheads) with 
wall thickening and haziness of the perivascular mediastinal fat. 
This aspect is consistent with a vasculitis.  b At the initial  18 F-fluo-
rodeoxyglucose positron emission tomography, there was just a 
mildly increased metabolic activity around the right pulmonary 
artery (arrowhead).  c Digital subtraction catheter pulmonary an-
giography showing disease extension beyond the hilum with just 
the lateral lower lobe segmental artery being patent. 
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 Over the last decade, evidence has emerged which 
links TB infection to TA and suggests that a previous TB 
infection could induce TA  [8–10] , implying that there 
might be an autoimmune cross-reactivity facilitated by 
vascular peptides that mimic  M. tuberculosis antigens 
 [11] . In this context, it is not likely that TA symptoms 
could be affected by treatment of the latent TB infection, 
but it is possible that TB infection is a sufficient trigger to 
induce TA. Research investigating the link between TB 
infection and TA is currently ongoing.
 There is relatively strong evidence supporting a link of 
polyarteritis nodosa with HBV, hepatitis C virus, and hu-
man immunodeficiency virus infection, leading to a nov-
el nomenclature for a subgroup of vasculitides called 
“vasculitis associated with probable cause”  [2] . However, 
only a handful of reports exist that have found an asso-
ciation between TA and HBV infection. These suggest 
that TA symptoms could be influenced by treatment of 
the underlying HBV infection and bring up the concept 
of HBV surface antigen levels or HBV viremia being re-
lated to TA activity  [12–14] . One report on the onset of 
TA after immunization with plasma-derived hepatitis B 
vaccine supports this idea  [15] . The association, however, 
could also be explained by the fact that both HBV infec-
tion and TA are more common in Asians than in other 
ethnicities. The patient described in this report had HBV 
viremia at the time of disease onset, potentially support-
ing the hypothesis that highly active HBV infection may 
trigger TA.
 Polyneuropathy can be a result of systemic vasculitis, 
which is also hypothesized as a trigger for TA. It would 
then typically involve the cervicobrachial plexus. On the 
other hand, polyneuropathy could also be associated with 
HBV infection but then would typically be associated 
with polyarteritis nodosa  [16] . It is uncertain which of the 
2 underlying diseases is responsible for the polyneuropa-
thy in the presented case, but since we advocate an iso-
lated involvement of the right pulmonary artery, the poly-
neuropathy is more likely to be due to the HBV infection 
or a nonrelated pathogenesis. 
 Along with an effectively controlled hepatitis B viral 
load and intensive immunotherapy with methotrexate, 
symptoms of TA markedly improved, while polyneurop-
athy showed little improvement. It is difficult to distin-
guish which of these 2 effects is responsible for symptom 
relief. Larger observational studies are needed to better 
define the potential triggering of TA by HBV infection.
 This case report adds to the concept of a potential as-
sociation of HBV infection and TB infection with the 
pathogenesis of TA. We advocate searching for HBV and 
TB infection in select patients with TA, as treatment of 
these conditions appears to improve the TA symptoms.
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 Fig. 2. Ultrasound-guided transbronchial fine-needle aspiration of 
the soft-tissue mass around the right pulmonary artery contains 
exclusively normal lymphatic tissue cells with anthracotic pigment 
containing histiocytes (arrows). HE stain of the cell block; original 
magnification ×400. 
 Fig. 3. After a 3-month anti-inflammatory treatment course (cor-
tisone and azathioprine), follow-up contrast-enhanced magnetic 
resonance angiography showed slight stenosis reduction with per-
sisting perivascular changes. The pulmonary branches remained 
occluded. 
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